MOLECULAR AND CELLULAR NEUROSCIENCE, published by Academic Press Inc Elsevier Science, is a pivotal journal dedicated to the expansive fields of Cellular and Molecular Neuroscience, providing a platform for the dissemination of innovative research and theoretical advancements since its establishment in 1990. With an ISSN of 1044-7431 and a commitment to high scholarly standards, this journal holds a notable Q2 ranking in key categories such as Cell Biology and Molecular Biology, highlighting its significant impact within the academic community. Although currently not an Open Access journal, it offers a wealth of insightful contributions aimed at fostering understanding and collaboration among researchers, professionals, and students. The journal's ongoing publication trajectory through to 2024 guarantees a continuous flow of cutting-edge research that is critical for addressing complex questions in neuroscience. As it plays a crucial role in advancing our understanding of molecular mechanisms underpinning neural function and pathology, MOLECULAR AND CELLULAR NEUROSCIENCE remains an essential reference for anyone invested in these dynamic fields.

CURRENT OPINION IN NEUROBIOLOGY, published by CURRENT BIOLOGY LTD, stands as a premier interdisciplinary journal in the field of neuroscience, specifically focusing on the latest advancements and emerging trends in neurobiology. With an impressive impact factor bolstered by its classification in Q1 in the Neuroscience (Miscellaneous) category and a notable Scopus rank of #16 out of 113 within General Neuroscience, this journal serves as an essential resource for academics, professionals, and students alike. Since its inception in 1991, CURRENT OPINION IN NEUROBIOLOGY has consistently provided insightful reviews covering various aspects of neurobiological research, thereby enhancing our understanding of complex neural processes. While the journal is not open access, it remains committed to disseminating high-quality research and fostering scholarly dialogue, making it a critical platform for those seeking to keep abreast of the dynamic developments in neuroscience.

Retrovirology is a prominent open-access journal published by BMC since 2004, dedicated to the field of retroviral research. With a strong focus on advancing knowledge in both infectious diseases and virology, this interdisciplinary journal has achieved a commendable ranking of Q2 in its respective categories as of 2023, reflecting its significant contribution to the scientific community. Hosted in the United Kingdom, Retrovirology serves a global audience of researchers, professionals, and students, making vital research accessible to all without barriers. The journal's emphasis on high-quality peer-reviewed articles supports the dissemination of groundbreaking findings that could shape the future of virology and related fields. With an impressive Scopus ranking, including a percentile of 65th in Medicine: Infectious Diseases, it stands out as a valuable resource for those committed to understanding and combating viral diseases. Retrovirology continues to be an essential platform for innovative research, with its open-access model ensuring that transformational science reaches the widest possible audience.

Molecular Brain is a prestigious open-access journal published by BMC, dedicated to advancing the field of neuroscience with a particular focus on cellular and molecular mechanisms. Since its inception in 2008, the journal has been committed to disseminating high-quality research that explores the intricate workings of the brain, particularly in areas related to cellular and molecular neuroscience. Located in the heart of London, England, Molecular Brain has garnered significant recognition in the academic community, boasting a 2023 categorization in the Q2 quartile for both Cellular and Molecular Neuroscience and Molecular Biology, reflecting its growing influence and relevance in these fields. With its Scopus ranks placing it in the top 32% and 38% of its respective categories, the journal serves as an essential platform for researchers, professionals, and students alike, encouraging collaboration and knowledge-sharing through its accessible online format.

Frontiers in Neuroscience, published by FRONTIERS MEDIA SA, is a premier open-access journal dedicated to advancing our understanding of the nervous system through innovative and rigorous research. Since its inception in 2007, this journal has become an influential platform for researchers, featuring a diverse range of topics across various subfields of neuroscience. With its current ranking in the second quartile (Q2) of the category "Neuroscience (miscellaneous)" and a commendable position of #40 out of 113 in general neuroscience according to Scopus, Frontiers in Neuroscience is recognized for its high-impact contributions. The journal promotes free access to scholarly work, ensuring that cutting-edge neuroscience studies reach a global audience and foster collaboration across disciplines. By bridging gaps in knowledge and facilitating the exchange of ideas, Frontiers in Neuroscience plays a pivotal role in addressing the complexities of the nervous system and its effects on behavior, cognition, and health.

CNS & Neurological Disorders-Drug Targets is a distinguished journal that focuses on contemporary research and advancements in the realms of neurology, pharmacology, and drug development. Published by Bentham Science Publishers, this journal serves as an essential platform for researchers, professionals, and students interested in the intricate workings of the central nervous system and the evolving strategies to target neurological disorders through pharmacological innovations. With a robust impact factor reflecting its academic relevance, CNS & Neurological Disorders-Drug Targets is categorized in the Q2 quartile for both Medicine (miscellaneous) and Pharmacology, and Q3 for Neuroscience in the 2023 rankings. The journal's Scopus rankings further reinforce its authority, positioning it within the top half of its categories. Operating out of the United Arab Emirates, the journal has been a loyal contributor to the scientific discourse since its inception in 2006 and will continue until at least 2024, ensuring a dynamic channel for the latest findings and reviews in this vital field. As an open-access publication, it prioritizes accessibility, thus fostering a wider impact among scholars and practitioners alike, making it a valuable resource for all stakeholders in neurological and pharmacological research.

The Annual Review of Neuroscience, published by Annual Reviews, is a premier journal that has been at the forefront of neuroscience research since its inception in 1978. With an ISSN of 0147-006X and E-ISSN 1545-4126, this leading academic journal boasts a remarkable impact factor, placing it in the prestigious Q1 category in Neuroscience (miscellaneous), with an impressive Scopus ranking of 4 out of 113 and a stellar 96th percentile in general neuroscience. Focused on publishing comprehensive and authoritative review articles, the Annual Review of Neuroscience aims to synthesize and critically evaluate the latest advances in the field, making it an indispensable resource for researchers, professionals, and students alike. While it does not offer open access, the insights and discoveries highlighted in its issues are crucial for those dedicated to understanding the complexities of the nervous system and driving forward innovative research. With a commitment to excellence and a forward-looking perspective, this journal continues to shape and influence the future of neuroscience.

Eneurobiologia is an esteemed open-access journal published by UNIV VERACRUZANA, INST INVESTIGACIONES & EDUCACION, dedicated to advancing research in the vibrant field of neurobiology. With its launch in 2010, the journal aims to disseminate high-quality, peer-reviewed research articles that explore the complexities of neural systems, neurodevelopment, and neurodegenerative disorders. By providing a platform for both established researchers and emerging scholars, Eneurobiologia fosters interdisciplinary collaboration and knowledge exchange within the scientific community. Its open-access model ensures that valuable findings are accessible to a global audience, promoting the widespread application of neurobiological research. As a crucial resource for students, professionals, and researchers alike, Eneurobiologia plays a pivotal role in shaping the future of neurobiological studies and enhancing our understanding of the brain and nervous system.

The Journal of Comparative Neurology, published by Wiley, stands as a cornerstone in the field of neuroscience since its inception in 1911. With an ISSN of 0021-9967 and an E-ISSN of 1096-9861, this esteemed journal spans a comprehensive scope of comparative neuroanatomy, neurophysiology, and neural development, providing critical insights into the intricate workings of nervous systems across species. The journal has earned a prestigious Q2 ranking in the category of general neuroscience for 2023, showcasing its substantial impact, reflected in its Scopus ranking of #47 out of 113 journals in its field. Researchers and professionals examining evolutionary patterns, neural structure functions, and comparative studies will find this journal an invaluable resource. Although it does not provide open access, its rigorous peer-review process ensures the publication of high-quality research that is crucial for advancing knowledge in comparative neurobiology. With a commitment to fostering scholarly exchange, the Journal of Comparative Neurology remains dedicated to exploring the complexities of the nervous system through a comparative lens, making it a vital platform for the global neuroscience community.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY is a premier journal dedicated to advancing the understanding of the intricate relationships between pathology and neurobiology. Published by Wiley since 1975, this journal has established itself as a crucial resource for researchers, clinicians, and students interested in the latest insights and developments in the fields of pathology, neurology, and neuroscience. With an impressive history of convergence extending to 2024, it boasts a Q1 ranking in multiple categories including Histology, Neurology, and Pathology, reflecting its high impact and reputation in the academic community. Additionally, it ranks 18th out of 208 in Pathology and Forensic Medicine with a remarkable 91st percentile, signifying its relevance and influence in medical research. While not open access, this journal provides valuable content that contributes significantly to the ongoing discourse in neurobiological advancements and is a vital reference for those engaged in this dynamic field.